Advancements in Cancer Theranostics Integrating Imaging and Intervention /
This book addresses the recent developments, trends, and challenges of nanosized biomedicine for solid tumors with reference to FDA approved imaging and therapeutic agents. In the last 25 years, about 300 nanosized imaging and therapeutic probes have been registered for clinical trials and only abou...
Furkejuvvon:
| Searvvušdahkki: | |
|---|---|
| Eará dahkkit: | , |
| Materiálatiipa: | Elektrovnnalaš E-girji |
| Giella: | eaŋgalasgiella |
| Almmustuhtton: |
Singapore :
Springer Nature Singapore : Imprint: Springer,
2025.
|
| Preanttus: | 1st ed. 2025. |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1007/978-981-95-0938-6 |
| Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Sisdoallologahallan:
- Chapter 1. Conventional and modern theranostics approaches
- Chapter 2. Functional nanohybrids for solid tumor theranostics
- Chapter 3. Optical activatable photosensitizers for imaging and therapy
- Chapter 4. Next-generation multimode imaging and synergestic therapuetics for solid tumors
- Chapter 5. Molecular imaging and therapuetics approaches
- Chapter 6. Choice of nanomedicine in cancer imaging and therapuetics
- Chapter 7. Clinical validations of localized cancer nanomedicine
- Chapter 8. Nano-scavengers in near infrared light mediated photothermal cancer therapy
- Chapter 9. Progress in Magneto-Luminescent Nanomaterials for Cancer Theragnosis
- Chapter 10. Nanomaterial-based contrast and therapuetics agents
- Chapter 11. Cancer Imaging and Scope of early stage diagnosis: molecular imaging modalities
- Chapter 12. Functional biomedicine for image guided therapuetics of solid tumor
- Chapter 13. Multifacated nanoimaging agents and pre-clinical/clinical examinations for localized theranostics
- Chapter 14. Biosafety and Realibility of NanoImaging and Therapuetics
- Chapter 15. Cancer Imaging and Theranostics Intervention: Current Status and Future Perspective.